209 related articles for article (PubMed ID: 23111496)
1. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.
Magee BA; Martin J; Cole MP; Morris KG; Courtney AE
Transplantation; 2012 Dec; 94(11):1111-6. PubMed ID: 23111496
[TBL] [Abstract][Full Text] [Related]
2. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
3. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
5. Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion.
Balasubramaniam GS; Morris M; Gupta A; Mesa IR; Thuraisingham R; Ashman N
Transplantation; 2012 Feb; 93(4):418-22. PubMed ID: 22228416
[TBL] [Abstract][Full Text] [Related]
6. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
[TBL] [Abstract][Full Text] [Related]
7. Causes of sensitisation in patients awaiting renal transplantation in Ireland.
Soosay A; O'Neill D; Counihan A; Hickey D; Keogan M
Ir Med J; 2003 Apr; 96(4):109-12. PubMed ID: 12793472
[TBL] [Abstract][Full Text] [Related]
8. Multi-array antibody screening in detecting antibodies to mismatched HLA in patients awaiting a second transplant.
Rosenberg JC; Berri R; Jackowski M; Levis D; Nehlsen-Cannarella S; Oh H
Transplant Proc; 2006 Dec; 38(10):3393-5. PubMed ID: 17175281
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
[TBL] [Abstract][Full Text] [Related]
11. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation.
Leffell MS; Kim D; Vega RM; Zachary AA; Petersen J; Hart JM; Rossert J; Bradbury BD
Transplantation; 2014 Mar; 97(5):525-33. PubMed ID: 24300013
[TBL] [Abstract][Full Text] [Related]
13. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
14. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
15. Immunological profile of patients awaiting a renal transplant.
Díaz I; Sánchez P; Alonso C; Valdés F
Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
[TBL] [Abstract][Full Text] [Related]
17. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
18. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
19. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
